Qatar vs Syrian Arab Republic: HIV-positive TB patients on ART (antiretroviral therapy)
Qatar
100.0%
in 2024
Syrian Arab Republic
100.0%
in 2021
Qatar rank
1st
Syrian Arab Republic rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Qatar
- Syrian Arab Republic
How they compare
Qatar currently reports 100.0% against 100.0% in Syrian Arab Republic, a difference of 0.0%.
Across all 6 years both countries report, Syrian Arab Republic has been ahead every year.
Qatar ranks 1st and Syrian Arab Republic ranks 1st of 144 countries.
Head to head by decade
| Decade | Qatar | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 100.0% | 100.0% | 0.0% | — |
| 2020s | 100.0% | 100.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Qatar or Syrian Arab Republic?
- Qatar, at 100.0% against 100.0% in Syrian Arab Republic as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Qatar and Syrian Arab Republic?
- 0.0%, with Qatar ahead.
- How many years of comparable data are there for Qatar and Syrian Arab Republic?
- 6 years are reported by both, from 2007 to 2021.
- How do Qatar and Syrian Arab Republic rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Qatar ranks 1st and Syrian Arab Republic ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.